HSR&D Citation Abstract
Search | Search by Center | Search by Source | Keywords in Title
Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).
Suda KJ, Traversa A, Patel U, Poggensee L, Fitzpatrick MA, Wilson GM, Evans CT. Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE). Infection control and hospital epidemiology. 2021 Nov 24; 1-4.
We assessed trends in treatment of patients with CRE from 2012 through 2018. We detected decreased utilization of aminoglycosides and colistin and increased utilization in extended-spectrum cephalosporins and ceftazidime-avibactam. We found significant uptake of ceftazidime-avibactam, a newly approved antibiotic, to treat CRE infections.